Diabetes Type Two
Showing 1 - 25 of >10,000
Diabetes, Diabetes, Type 1, Lipohypertrophy Trial in Roma (Medtronic Extended Infusion Set)
Completed
- Diabetes
- +2 more
- Medtronic Extended Infusion Set
-
Roma, ItalyAzienda Ospedaliera San Camillo Forlanini
Oct 6, 2023
Diabetes, Type 2, Overweight or Obesity Trial (HIIT snacks, Sprint snacks, Control)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Overweight or Obesity
- HIIT snacks
- +2 more
- (no location specified)
Nov 22, 2023
Type 1 Diabetes Trial (teplizumab)
Not yet recruiting
- Type 1 Diabetes
- teplizumab
- (no location specified)
Mar 6, 2023
Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Guangzhou (AndroidAPS-rt-CGM;, sensor augmented pump(SAP);)
Recruiting
- Diabetes Mellitus
- +6 more
- AndroidAPS-rt-CGM;
- sensor augmented pump(SAP);
-
Guangzhou, Guangdong, ChinaJinhua Yan
Feb 12, 2023
Type 1 Diabetes Trial in Doha (Simple meal management, Precise meal management)
Recruiting
- Type 1 Diabetes
- Simple meal management
- Precise meal management
-
Doha, Qa, QatarSidra Medicine
Nov 13, 2023
Type 1 Diabetes Trial (CamAPS HX, Standard insulin pump therapy with CGM)
Not yet recruiting
- Type 1 Diabetes
- CamAPS HX
- Standard insulin pump therapy with CGM
- (no location specified)
Dec 7, 2022
Subjects With T2D or at Risk of T2D Cohort Follow-up
Not yet recruiting
- Diabetes Mellitus, Type 2
- OGTT
- +2 more
-
Évry, FranceCentre d'Etudes et de Recherche pour l'Intensification du Traite
Dec 23, 2022
Type 2 Diabetes, Malnutrition Trial in Málaga (Diabetic, Control)
Completed
- Type 2 Diabetes
- Malnutrition
- Diabetic
- Control
-
Málaga, SpainJosé M. García Almeida
Jun 14, 2022
Diabetes, Diabetes Complications Trial in Reading (Usual Care, F&V Rx alone, F&V Rx plus DSME/S)
Not yet recruiting
- Diabetes Mellitus
- Diabetes Complications
- Usual Care
- +2 more
-
Reading, PennsylvaniaPenn State Health St. Joseph Downtown Campus
Oct 24, 2023
Diabetes, Type 2 Trial in Pembroke Pines (Semaglutide J, Semaglutide B)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Semaglutide J
- Semaglutide B
- (no location specified)
Aug 10, 2022
Type 1 Diabetes Trial in Portland (MPC AP algorithm, Robust R-AP algorithm)
Completed
- Type 1 Diabetes
- MPC AP algorithm
- Robust R-AP algorithm
-
Portland, OregonOregon Health and Science University
Jan 3, 2023
Diabetes Complication, Renal Impairment Trial in Uddevalla (Simultanious CGM/FGM)
Active, not recruiting
- Diabetes Mellitus Complication
- Renal Impairment
- Simultanious CGM/FGM
-
Uddevalla, SwedenNU-Hospital Group
May 2, 2022
Diabetes, Type 1 Diabetes Trial in Bern (Low carbohydrate diet, balanced diet)
Withdrawn
- Diabetes
- Type 1 Diabetes
- Low carbohydrate diet
- balanced diet
-
Bern, SwitzerlandUniversity Department of Endocrinology, Diabetology, Clinical Nu
Dec 15, 2022
Diabetes Trial in Lahore (Oral Hypoglycemic Agents,Oral, Voreta, Voreta plus SunnyD PRO)
Not yet recruiting
- Diabetes Mellitus
- Oral Hypoglycemic Agents,Oral
- +2 more
-
Lahore, Punjab, PakistanUniversity of Health Sciences
Jun 10, 2022
Type 2 Diabetes Trial in San Francisco, Ann Arbor (Very low-carbohydrate diet, Moderate-carbohydrate plate-method diet)
Recruiting
- Type 2 Diabetes
- Very low-carbohydrate diet
- Moderate-carbohydrate plate-method diet
-
San Francisco, California
- +1 more
Jul 3, 2022
Type 1 Diabetes Trial in Bobo-Dioulasso, Ouagadougou (premix insulin human isophane suspension and insulin human, Humulin N plus
Not yet recruiting
- Type 1 Diabetes
- premix insulin human isophane suspension and insulin human
- Humulin N plus Humulin R
-
Bobo-Dioulasso, Houet, Burkina Faso
- +2 more
Mar 12, 2023
Diabetes, PreDiabetes, Diet Habit Trial (CURE-DM)
Not yet recruiting
- Diabetes Mellitus
- +2 more
- CURE-DM
- (no location specified)
Jun 22, 2023
Type 1 Diabetes Trial in Bern (SMA bolus option, Exactly estimated carbohydrate content bolus option)
Not yet recruiting
- Type 1 Diabetes
- SMA bolus option
- Exactly estimated carbohydrate content bolus option
-
Bern, SwitzerlandDepartment of Diabetes, Endocrinology, Nutritional Medicine and
Aug 10, 2022
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
-
San Pedro Garza García, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release
Completed
- Bioequivalence
- Diabetes Mellitus, Type 2
- Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
-
San Pedro Garza Garcia, Nuevo León, MexicoAvant Santé Research Center S.A. de C.V.
Nov 8, 2023
Diabetes, Type 2 Trial in Accra (DESMOND, usual care)
Completed
- Diabetes Mellitus, Type 2
- DESMOND
- usual care
-
Accra, Ghana
- +1 more
Aug 12, 2022